Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

被引：0
|
作者：
Nath, Rajneesh [1 ]
Cerny, Jan [2 ]
Ramanathan, Muthalagu [3 ]
Zhou, Zheng [2 ]
Yu, Neng [4 ]
Raffel, Glen D. [5 ]
Bednarik, Jayde [6 ]
机构：
[1] Banner MD Anderson Canc Ctr, Div Hematol Oncol, BMT & Acute Leukemia Program, Gilbert, AZ USA
[2] Univ Massachusetts, Med Sch, Dept Med, Div Hematol Oncol, Worcester, MA USA
[3] Univ Massachusetts Mem Ctr, Div Hematol, Dept Internal Med, Worcester, MA USA
[4] UMass Mem Med Ctr, HLA Lab, Worcester, MA USA
[5] Univ Massachusetts Med Sch, Div Hematol Oncol, Worcester, MA USA
[6] UMass Mem Med Ctr, Worcester, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5875.5875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5875
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Cure by chemotherapy without allogeneic stem cell transplantation (ALLO-SCT) in pediatric relapsed acute myeloid leukemia (AML)?
    Kaspers, G. J. L.
    Goemans, B. F.
    Korbijn, C.
    Tamminga, R. Y.
    Hahlen, K.
    ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [12] Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.
    Ayari, Sameh
    Mohty, Mohamad
    Bilger, Karin
    Guillerm, Gaelle
    Guyotat, Denis
    Michallet, Mauricette
    Ifrah, Norbert
    Chevallier, Patrice
    BLOOD, 2009, 114 (22) : 1281 - 1282
  • [13] EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)
    Abello, V
    Rosales, C.
    Pedraza, E.
    Linares, A.
    Esguerra, H.
    Rosales, M.
    Figueroa, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S232 - S232
  • [14] Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia (AML) or Myelodysplastic Syndrome (MDS) in Patients (pts) Older Than 50 Years: a Retrospective Single Center Study
    Robin, Marie
    Porcher, Raphael
    Ades, Lionel
    Raffoux, Emmanuel
    de Latour, Regis Peffault
    Petropoulou, Anna
    Boissel, Nicolas
    Ribaud, Patricia
    Devergie, Agnes
    Rocha, Vanderson
    Fenaux, Pierre
    Dombret, Herve
    Socie, Gerard
    BLOOD, 2008, 112 (11) : 1136 - 1136
  • [15] Outcome or allogeneic stem cell transplantation (SCT) in patients with myelodisplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML). A retrospective single center analysis.
    Rubio, S
    Martins, C
    Lacerda, JF
    Carmo, JA
    Lourenco, F
    Juncal, C
    Rodrigues, A
    Lacerda, JMF
    BLOOD, 2002, 100 (11) : 338B - 338B
  • [16] Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL)
    Al Malki, Monzr M.
    Aldoss, Ibrahim
    Forman, Stephen J.
    Stiller, Tracey
    Pullarkat, Vinod A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S175 - S175
  • [17] Allogeneic stem cell transplantation (allo-SCT) in patients with advanced-phase acute leukemia
    Michalakeas, I
    Baltathakis, I
    Karakasis, D
    Delistrati, V
    Poulopoulou, Z
    Bika, E
    Skandalis, A
    Harhalakis, N
    Nikiforakis, E
    BONE MARROW TRANSPLANTATION, 2002, 29 : S81 - S81
  • [18] Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)
    Shimizu, Hiroaki
    Ishizaki, Takuma
    Hatsumi, Nahoko
    Takada, Satoru
    Yokohama, Akihiko
    Saitoh, Takayuki
    Sakura, Toru
    Handa, Hiroshi
    BLOOD, 2019, 134
  • [19] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute myeloid leukemia (AML): A donor versus no donor comparison
    Mohty, M
    de Lavallade, H
    Ladaique, P
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Blaise, D
    BLOOD, 2005, 106 (11) : 439B - 439B
  • [20] Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myelogenous Leukemia (AML). Final Analysis of JALSG AML97 Study
    Sakamaki, Hisashi
    Miyawaki, Shuichi
    Ohtake, Shigeki
    Emi, Nobuhiko
    Yagasaki, Fumiharu
    Mitani, Kinuko
    Matsuda, Shin
    Kishimoto, Yuuji
    Miyazaki, Yasushi
    Asou, Norio
    Takahashi, Masatomo
    Ogawa, Yoshiaki
    Honda, Sumihisa
    Ohno, Ryuzo
    BLOOD, 2008, 112 (11) : 135 - 136
12345